Lixa Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $3.25M

  • Investors
  • 1

Lixa General Information

Description

Operator of an anti-biofilm platform intended to treat antimicrobial resistance. The company's platform develops scalable antibiofilm technologies to prevent the formation of bacterial biofilm colonies, break down established biofilms, leaving bacteria unprotected and unattached, and target the basic integrity of biofilms for broad applicability and reliability, enabling patients to fight against antimicrobial resistance by dissolving the biofilm and making bacteria vulnerable again.

Contact Information

Website
www.lixa.life
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 22 Stirling Highway
  • Level 1
  • Nedlands, Western Australia 6009
  • Australia
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 22 Stirling Highway
  • Level 1
  • Nedlands, Western Australia 6009
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lixa Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 25-Aug-2025 $3.25M Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 01-Jan-2022 Completed Clinical Trials - Phase 1
To view Lixa’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Lixa Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lixa Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Melt Ventures Venture Capital Minority
To view Lixa’s complete investors history, request access »

Lixa FAQs

  • When was Lixa founded?

    Lixa was founded in 2021.

  • Where is Lixa headquartered?

    Lixa is headquartered in Nedlands, Australia.

  • What is the size of Lixa?

    Lixa has 16 total employees.

  • What industry is Lixa in?

    Lixa’s primary industry is Drug Discovery.

  • Is Lixa a private or public company?

    Lixa is a Private company.

  • What is Lixa’s current revenue?

    The current revenue for Lixa is .

  • How much funding has Lixa raised over time?

    Lixa has raised $4.82M.

  • Who are Lixa’s investors?

    Melt Ventures has invested in Lixa.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process